跳至主要内容
临床试验/DRKS00032051
DRKS00032051招募中不适用

Intra- and postoperative microbiome in pancreatic carcinoma to determine prognostic factors of postoperative morbidity and tumor recurrence - PancBIOME - PancBIOME

Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Ludwig-Maximilians-Universität (LMU) München0 个研究点目标入组 250 人开始时间: 2023年6月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with resectable tumor of the pancreas scheduled for tumor resection, especially of the head of the pancreas, i
  • - Ability to consent at the time of inclusion in the study
  • - Must be of legal age at the time of admission to the study

排除标准

  • - Inability to consent or underage at the time of inclusion in the study.
  • - Mental or physical disorders that could affect informed consent or treatment
  • - Individuals with understanding/language problems or inability to comply with study and/or follow-up procedures
  • - Any contraindication to surgery
  • - Acute or ongoing episode of pancreatitis (clinical symptoms of pancreatitis, elevated lipase and/or CRP levels, radiological or intraoperative signs of acute pancreatitis)

研究者

发起方
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Ludwig-Maximilians-Universität (LMU) München

相似试验